4//SEC Filing
Ouzren Nawal 4
Accession 0001628280-21-012280
CIK 0001080709other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:25 PM ET
Size
7.2 KB
Accession
0001628280-21-012280
Insider Transaction Report
Form 4
Ouzren Nawal
Director
Transactions
- Award
Common Stock
2021-06-11+3,067→ 4,555 total - Award
Stock Option (right to buy)
2021-06-11+7,202→ 7,202 totalExercise: $65.19Exp: 2028-06-11→ Common Stock (7,202 underlying)
Footnotes (2)
- [F1]The amount represents restricted stock units that vest in full on the earliest of June 11, 2022, or the date of Arena's next annual meeting of stockholders. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
- [F2]The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 11, 2021 with the final installment vesting upon the earlier of the one-year anniversary of the grant date or the date of the next annual stockholders' meeting, and are exercisable once vested.
Documents
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeother
Related Parties
1- filerCIK 0001846836
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 5:25 PM ET
- Size
- 7.2 KB